Rule 1301:18-4-18 | Research by Testing Laboratory Licensed by Chapter 4729:5-16 of the Administrative Code.
(A) Prior to any sale, transfer, or distribution of cannabis pursuant to this rule, a cultivator or processor may request in a manner prescribed by the division of cannabis control to sell cannabis to a laboratory licensed under Chapter 4729:5-16 of the Administrative Code, to possess dangerous drugs and controlled substances solely for scientific, clinical, research, or development purposes.
(B) Upon receipt of a request the division may:
(1) Approve the request;
(2) Approve the request, subject to certain mandates or limitations;
(3) Advise the licensee in writing that further information is needed;
(4) Deny the request.
(C) Upon receipt of written approval by the division, a licensee may proceed and sell cannabis pursuant to this rule.
(D) A licensee seeking to sell cannabis pursuant to this rule is to apply to the division for each sale of cannabis.
(E) Any and all associated cannabis tested pursuant to this rule must be solely intended for scientific or clinical research or development.
A licensee shall not utilize this rule to:
(1) Submit any test sample to a testing laboratory prior to any state-required testing.
(2) In place or a substitution of, any state-required testing as outlined under division 1301:18 of the Administrative Code.
(3) Attempt to circumvent any standards or mandates established by the division pertaining to state-required testing, including any procedures, requirements, directives.
(F) Unless and until a licensee receives written approval from the division, a licensee shall not transfer, sell, or distribute cannabis pursuant to this rule.
(G) Pursuant to rule 1301:18-3-14 of the Administrative Code, any cannabis transferred, sold, or distributed pursuant to this rule must be recorded in the state inventory tracking system.
Last updated October 9, 2025 at 8:11 AM
Supplemental Information